Clinical Trials Directory

Trials / Completed

CompletedNCT01610804

Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Choroidal Thickness Measurements During CSCR Treatment Applying EDI-OCT Technology

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
University Hospital Regensburg · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT). Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2011-11-01
Completion
2012-05-01
First posted
2012-06-04
Last updated
2012-06-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01610804. Inclusion in this directory is not an endorsement.